conclusively , 750 mg b.i.d . of s6472 is anticipative of the same clinical efficacy , safety and usefulness as compared with that of 750 mg t.i.d . of ccl in the treatment of skin and soft tissue infections .
C0007537
ccl
C0149778
soft tissue infections